期刊文献+

抗原致敏树突状细胞诱导CTL杀伤K562细胞体外实验研究

In vitro study of cytotoxic T lymphocyte activation by antigen-loaded dendritic cells for killing of K562 cells
下载PDF
导出
摘要 目的研究体外负载K562细胞冻融抗原的树突状细胞(DC)诱导细胞毒性T淋巴细胞(CTL)的特异性杀伤作用。方法联合应用细胞因子从外周血单个核细胞(PBMC)诱导培养出DC,在体外负载K562细胞冻融抗原。采用乳酸脱氢酶释放法,对比K562冻融抗原致敏DC组、未致敏DC组、淋巴细胞组、前列腺癌PC3冻融抗原致敏DC组分别激活的CTL对K562细胞的杀伤作用。结果培养出具有典型特征的DC;在效靶比为10:1及20:1时,K562冻融抗原致敏DC组诱导的CTL对K562细胞的杀伤率分别为55.9%±22.0%、90.2%±24.8%,均高于其他3组(P<0.05)。结论K562细胞冻融抗原致敏DC可诱导激活CTL,具有明显杀伤K562细胞作用,并具有特异性。 Objective To study the effect of dendritic cells (DC) stimulated with K562 cell lysate in inducing specific cytotoxic T lymphocytes (CTL) against K562 cells in vitro. Methods The DCs were derived from healthy human peripheral blood monocytes in the presence of granulocyte-macrophage colony-stimulating factor, interlenkin (IL)-4 and tumor necrosis factor (TNF) α. The T cells were stimulated by DCs loaded with freeze-thawed K562 cells and T-cell cytotoxicities were measured by lactate dehydrogenase (LDH) assay. Results The DCs could be successfully obtained from peripheral blood monocyte after the culture. Mixed lymphocyte reactions induced by the antigen-loaded DC were much stronger than those induced by human peripheral blood monocytes (P〈0.05). At the effector to target ratio of 10:1 and 20:1, cytotoxicities against K562 cells by CTL derived from culture with the antigen-loaded DCs were the strongest (P〈0.05). Conclusion CTL derived from DCs pulsed with K562 cell lysate show effecitive and specific cytotoxicity against K562 cells.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2006年第5期617-619,共3页 Journal of Southern Medical University
基金 广东省自然科学基金(31713)~~
关键词 树突状细胞 K562细胞 细胞毒T淋巴细胞 dendritic cells K562 cells cytotoxic T lymphocyte
  • 相关文献

参考文献5

  • 1Notter M, Willinger T, Erben U, et al. Targeting ofa B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells [J].Blood, 2001,97:3138-45.
  • 2Banchereau J, Steinman RM. Dendritic cells and the control of immunity[J]. Nature, 1998, 392(6678): 245-52.
  • 3Liu Y, Zhang W, Chan T, et al. Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity[J]. Leuk Res, 2002, 26(8): 757-63.
  • 4Goddard RV, Prentice AG, Copplestone JA, et al. In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids[J]. Clin Exp Immunol, 2003, 131(1): 82-9.
  • 5Angel P, Eli G. Bone marrow-generated dendritic cells pulsed with a class Ⅰ -restricted peptide are potent inducers of cytotoxic T lymphocyte[J]. Exp Med, 1995, 182(1): 255-60.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部